| Nathan Turley, DPT | |
|
3701 Messina Dr Ste 108, Farmington, NM 87402-4780 | |
| (505) 258-4003 | |
| (505) 436-2740 |
| Full Name | Nathan Turley |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 3701 Messina Dr Ste 108, Farmington, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114632312 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT22053 (New Mexico) | Primary |
| Provider Name | Three Rivers Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1811256860 PECOS PAC ID: 1153543632 Enrollment ID: O20141118001436 |
News Archive
A new meta-analysis, released on the medRxiv* preprint server, suggests that, though possible, the virus is rarely transmitted to the newborn in real life. A scientific brief from the World Health Organization (WHO) in February 2021 describes three mechanisms by which the virus might be transmitted from the mother to the fetus or newborn.
The recent dramatic increase in the fall death rate in older Americans is likely the effect of improved reporting quality, according to a new report from the Johns Hopkins Center for Injury Research and Policy.
LSU Health Sciences Center New Orleans has been awarded $12 million over five years by the National Institutes of Health to conduct research on diseases like prostate and stomach cancers, lymphoma and leukemia, dengue fever, tuberculosis, and herpes infections, as well as to support the development of academic research scientists.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the United States Food and Drug Administration has removed the partial clinical hold on the Company's aldoxorubicin clinical trials.
Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nathan Turley, DPT 3701 Messina Dr Ste 108, Farmington, NM 87402-4780 Ph: (505) 258-4003 | Nathan Turley, DPT 3701 Messina Dr Ste 108, Farmington, NM 87402-4780 Ph: (505) 258-4003 |
News Archive
A new meta-analysis, released on the medRxiv* preprint server, suggests that, though possible, the virus is rarely transmitted to the newborn in real life. A scientific brief from the World Health Organization (WHO) in February 2021 describes three mechanisms by which the virus might be transmitted from the mother to the fetus or newborn.
The recent dramatic increase in the fall death rate in older Americans is likely the effect of improved reporting quality, according to a new report from the Johns Hopkins Center for Injury Research and Policy.
LSU Health Sciences Center New Orleans has been awarded $12 million over five years by the National Institutes of Health to conduct research on diseases like prostate and stomach cancers, lymphoma and leukemia, dengue fever, tuberculosis, and herpes infections, as well as to support the development of academic research scientists.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the United States Food and Drug Administration has removed the partial clinical hold on the Company's aldoxorubicin clinical trials.
Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.
› Verified 6 days ago
Mr. Roger G. Rung, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2700 Farmington Ave, Farmington, NM 87401 Phone: 505-326-0761 | |
Anne Tolman Price, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 W Maple St, Farmington, NM 87401 Phone: 505-325-2511 | |
Mr. Greg David Mcmanus, PT, ATC Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 511 E 20th St, Farmington, NM 87401 Phone: 505-326-0064 Fax: 505-327-3995 | |
Four Corners Physical Therapy Limited Partnership Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3832 E Main St, Units E & F, Farmington, NM 87402 Phone: 505-564-2955 Fax: 505-564-2662 | |
Katherine Reardon, P.T., D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3832 E Main St, Units E And F, Farmington, NM 87402 Phone: 505-564-2955 Fax: 505-564-2662 | |
Neerly Famous Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2501 E 20th St., Suite #4, Farmington, NM 87401 Phone: 505-325-8360 Fax: 505-327-2424 | |
Caryl Ventura, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2800 Hutton Ave, Farmington, NM 87402 Phone: 505-215-0179 |